NCT04598581View on ClinicalTrials.gov

Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

April 9, 2021

Study Completion Date

April 9, 2021

Conditions
Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)
Interventions
RADIATION

Low Dose Radiation Therapy (LD-RT)

Low Dose Radiation Therapy (LD-RT) of both lungs with 1 Gray

OTHER

Sham irradiation

Sham irradiation

Trial Locations (1)

4031

Department of Radiooncology, University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT04598581 - Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 | Biotech Hunter | Biotech Hunter